Home › Conditions › Alcohol Withdrawal Syndrome
neurology
Alcohol Withdrawal Syndrome
Alcohol withdrawal begins 6–24 hours after last drink. Minor symptoms peak at 24–36h; seizures at 24–48h; delirium tremens (DTs) at 48–72h with peak mortality. Assess severity with CIWA-Ar score. All patients need Pabrinex (thiamine) to prevent…
CIWA-Ar / Chlordiazepoxide Protocol
The pathway
1 · CIWA-Ar assessment
Score: nausea/vomiting, tremor, sweating, anxiety, agitation, perceptual disturbances, headache, clouding of sensorium. Mild ≤8, moderate 9–15, severe ≥16. Repeat 4-hourly minimum.
2 · Wernicke's prophylaxis — MANDATORY
Three different situations, three different regimens (BNF):
- Lower risk, eating normally: oral thiamine
- Prophylaxis in assisted withdrawal as an inpatient: Pabrinex 1 pair OD IM for 5–7 days
- Suspected or established Wernicke’s: Pabrinex 2–3 pairs TDS IV for 3–5 days, then 1 pair OD for a further 3–5 days
3 · Chlordiazepoxide protocol (front-loading)
4 · Seizure management
Alcohol withdrawal seizure: benzodiazepines (lorazepam 2–4mg IV) first-line. Do NOT use phenytoin (not effective for alcohol withdrawal seizures). Chlordiazepoxide regime may need increasing.
5 · Delirium Tremens (DTs)
DTs: acute confusion + autonomic instability (tachycardia, hypertension, fever, sweating). ITU if severe. High-dose benzodiazepines IV. Monitor electrolytes (hyponatraemia, hypomagnesaemia, hypophosphataemia). Mortality 5–15% if untreated.
6 · Monitoring & discharge
Daily CIWA-Ar. U&E, LFTs, Mg, phosphate. BM monitoring. Seizure precautions (no driving, no heights). Alcohol withdrawal can last 7–10 days. AUDIT-C for alcohol use disorder assessment. Refer to alcohol specialist services / community detox.
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Pabrinex (IV thiamine) | Prophylaxis 1 pair OD; Wernicke’s 2–3 pairs TDS | IM (prophylaxis) / IV infusion (treatment) | Prophylaxis and treatment are different doses — 1 pair OD for 5–7 days in assisted withdrawal; 2–3 pairs TDS for 3–5 days if Wernicke’s is suspected. Anaphylaxis risk — give where resuscitation is available. |
| Chlordiazepoxide | 10–40mg QDS + PRN 10–20mg | PO | Titrate to CIWA-Ar. Taper over 7 days. Avoid in liver failure (use lorazepam). |
| Lorazepam | 1–4mg | IV/IM | If cannot take oral, or active seizure. Short-acting benzodiazepine. |
| Haloperidol | 0.5–2mg | PO/IM | Adjunct for severe agitation in DTs. Does NOT treat withdrawal per se. |
When to escalate
CIWA-Ar ≥16 or DTs — high-dependency environment,Seizure — benzodiazepines IV, consider ITU,Wernicke's encephalopathy (confusion, ataxia, ophthalmoplegia) — Pabrinex 2–3 pairs TDS IV for 3–5 days, senior review,Haemodynamic instability in DTs — ITU
Reference: NICE CG100 Alcohol-Use Disorders / BAP Guidelines 2018
This page is the reference half
The app adds what a web page cannot: a VINDICATE differential builder, worked on-call scenarios with full A–E findings, recall practice, and all of it offline.